null

SMILES Nc1ncnc2n(CC3CCNCC3)nc(-c3ccc4cc(OCc5cccc(Cl)c5)ccc4c3)c12

InChI Key InChIKey=NRRBFJRUKPITFY-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 11 hits for monomerid = 50389700   

TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University of Washington

Curated by ChEMBL
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 380nMAssay Description:Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphorimaging methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P2706VPubMed
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University of Washington Through its Center for Commercialization

US Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:Most known kinase inhibitors bind in the ATP-binding pocket of the active site19,20. These inhibitors exploit many of the same hydrophobic contacts a...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B56MVCUS Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
University of Washington Through its Center for Commercialization

US Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 0.600nMAssay Description:Two types of enzyme assays were developed to follow TgCDPK1 activity, a radiometric scintillation proximity assay measured the labeled γ-phospha...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B56MVCUS Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University of Washington

Curated by ChEMBL
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 375nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B56MVCUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
University of Washington Through its Center for Commercialization

US Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 497nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B56MVCUS Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 0.600nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2K077GQUS Patent
TargetCalmodulin-domain protein kinase 1, putative(Cryptosporidium parvum (strain Iowa II))
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO

US Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 0.600nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D79DSFUS Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University of Washington

Curated by ChEMBL
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 375nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D79DSFUS Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
University of Washington Through its Center for Commercialization

US Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 497nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D79DSFUS Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2K077GQUS Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University of Washington Through its Center for Commercialization

US Patent
LigandPNGBDBM50389700(CHEMBL2070067 | US10544104, Compound 38 | US112479...)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D79DSFUS Patent